See more : Star Diamond Corporation (DIAM.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Onward Medical N.V. (ONWD.BR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Onward Medical N.V., a leading company in the Biotechnology industry within the Healthcare sector.
- Dexin China Holdings Company Limited (2019.HK) Income Statement Analysis – Financial Results
- WU BA Superior Products Holding Group Inc. (WBWB) Income Statement Analysis – Financial Results
- Lodzia Real Estate Ltd. (LODZ.TA) Income Statement Analysis – Financial Results
- ecotel communication ag (E4C.DE) Income Statement Analysis – Financial Results
- Canntab Therapeutics Limited (CTABF) Income Statement Analysis – Financial Results
Onward Medical N.V. (ONWD.BR)
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARCEX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer, which restores or enhances physical movement of hand and arm function to people with spinal cord therapy; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord that enables long-paralyzed people to stand and walk again with little or no assistance. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of ARCEX Therapy in restoring strength and function of upper extremities in people with spinal cord injury. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 532.00K | 2.15M | 1.40M | 800.00K | 554.00K | 474.00K |
| Cost of Revenue | 15.35M | 14.69M | 4.05M | 2.31M | 838.00K | 1.04M |
| Gross Profit | -14.82M | -12.54M | -2.65M | -1.51M | -284.00K | -567.00K |
| Gross Profit Ratio | -2,785.34% | -583.75% | -189.28% | -188.63% | -51.26% | -119.62% |
| Research & Development | 13.84M | 13.14M | 7.93M | 5.82M | 5.36M | 4.72M |
| General & Administrative | 11.33M | 8.07M | 6.24M | 2.67M | 2.25M | 1.25M |
| Selling & Marketing | 2.94M | 1.95M | 1.52M | 394.00K | 261.00K | 98.00K |
| SG&A | 15.73M | 10.02M | 7.76M | 3.07M | 2.51M | 1.34M |
| Other Expenses | -8.93M | 7.32M | 8.80M | 4.32M | 2.07M | 1.30M |
| Operating Expenses | 20.65M | 17.34M | 24.49M | 13.20M | 9.93M | 7.36M |
| Cost & Expenses | 36.00M | 32.03M | 28.53M | 15.51M | 10.77M | 8.41M |
| Interest Income | 0.00 | 62.00K | 1.00K | 4.43M | 1.00K | 0.00 |
| Interest Expense | 600.00K | 1.52M | 5.60M | 4.43M | 2.67M | 1.49M |
| Depreciation & Amortization | 229.00K | 735.00K | 329.00K | 246.00K | 229.00K | 213.00K |
| EBITDA | -35.23M | -31.26M | -28.30M | -15.29M | -10.54M | -8.17M |
| EBITDA Ratio | -6,622.93% | -1,456.61% | -2,024.23% | -1,911.63% | -1,903.25% | -1,724.26% |
| Operating Income | -35.46M | -32.03M | -28.53M | -15.51M | -10.77M | -8.41M |
| Operating Income Ratio | -6,665.98% | -1,491.06% | -2,039.46% | -1,939.00% | -1,944.40% | -1,773.21% |
| Total Other Income/Expenses | -611.00K | -1.51M | -5.71M | -4.48M | -2.67M | -1.49M |
| Income Before Tax | -36.07M | -33.54M | -34.25M | -19.99M | -13.44M | -9.89M |
| Income Before Tax Ratio | -6,780.83% | -1,561.36% | -2,447.82% | -2,499.25% | -2,426.71% | -2,087.34% |
| Income Tax Expense | 107.00K | -766.00K | 69.00K | 20.00K | 39.00K | 18.00K |
| Net Income | -36.18M | -32.77M | -34.31M | -20.01M | -13.48M | -9.91M |
| Net Income Ratio | -6,800.94% | -1,525.70% | -2,452.75% | -2,501.75% | -2,433.75% | -2,091.14% |
| EPS | -1.20 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| EPS Diluted | -1.20 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| Weighted Avg Shares Out | 30.15M | 30.18M | 30.18M | 20.83M | 20.83M | 20.83M |
| Weighted Avg Shares Out (Dil) | 30.18M | 30.18M | 30.18M | 20.83M | 20.83M | 20.83M |
Source: https://incomestatements.info
Category: Stock Reports